Reciprocal feedback between these pathways allows tumor cells to escape therapy as AR inhibition can activate AKT signaling via increased phosphorylation, while AKT blockade can stimulate AR signaling, promoting cancer progression [59]. The gene discussed is AKT1; the disease is neoplasm.